After removal of the warning, cephalosporin use increased from 17.9% to 27.0% at the intervention site. Removal of the default warning in the electronic health record (EHR) urging the avoidance of ...

Please provide your email address to receive an email when new articles are posted on . 49 of 50 patients with penicillin allergy tolerated 76 of 77 doses of cephalosporins. 70% of reactions were low ...

Covina, April 05, 2023 (GLOBE NEWSWIRE) -- Cephalosporin drugs are a class of antibiotics that are widely used in the treatment of bacterial infections. They are structurally similar to penicillin and ...

Please provide your email address to receive an email when new articles are posted on . A history-based risk stratification of cephalosporin allergy labels appeared feasible when using the validated ...

Cefiderocol, a novel parenteral siderophore cephalosporin, exhibits potent in vitro activity and in vivo efficacy against most gram-negative bacteria, including carbapenem-resistant strains of ...

ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...

Senior Clinical Pharmacy Specialist in Infectious Diseases, Department of Pharmacy, Albany Medical Center Hospital, Albany, New York The safety of a penicillin in a cephalosporin-allergic patient ...

Purpose. The pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of ceftobiprole are reviewed. Conclusion. Ceftobiprole is a novel ...

Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business. The company said the move is aimed at reinforcing its leading global position in antibiotics.

Basilea achieves a breakthrough with the US FDA approval for a new therapy for the treatment of severe infections, the first by the FDA after more than 15 years. Basilea’s Zevtera gets U.S. FDA ...

Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The ...